Omega-3s, APOE4 and the 700 Cholesterol Puzzle: Dr Nick Norwitz on Brain Longevity
Dr Nick Norwitz explains why the brain craves DHA yet standard omega-3 supplements underdeliver, why the carrier form and APOE4 genotype change everything, and how he weighs statins, tau, and lithium for brain longevity. Along the way he unpacks his headline-grabbing case report: seven years of 700 cholesterol with zero arterial plaque.
Overview
Neuroscientist Louisa Nicola sits down with Dr Nick Norwitz to untangle the omega-3 paradox: eating fish tracks with lower Alzheimer's risk, yet trials of standard supplements disappoint. Norwitz argues the trials are too short and often use the wrong carrier — the phospholipid (lysophosphatidylcholine) form of DHA locks onto the MFSD2A transporter and concentrates in the brain far better than ordinary triglyceride fish oil.
The conversation turns to APOE4, the gene he carries in double copy: a risk multiplier, not a sentence, whose brains appear to burn through DHA faster and demand more aggressive protection. They explore under-discussed sex differences, from menopause and estrogen to X-chromosome DHA genes and statin side effects in women. Norwitz makes a careful case that LDL is causal but not the same as important, illustrated by his own report of 700 cholesterol with zero plaque.
He walks through tau as the emerging Alzheimer's frontier, the p-tau 217 blood biomarker, lithium orotate and GSK3-beta, and the glymphatic clean-up that happens in deep sleep. Lighter self-experiments — the Oreo cholesterol drop and a month of a thousand sardines that boosted thermogenesis — bookend a recurring theme: study the outliers, respect people's intelligence, and hold opinions loosely. Shared as wellness education, never medical advice.
Key quotes
57 years of 700 cholesterol without coronary atherosclerosis. And the patient in the case report was you.
If you're an APOE4 like me, chronic sleep deprivation will screw you. There is no wiggle room.
Causal does not mean important.
I used Oreos to lower my cholesterol by 71%.
You always learn the most from studying the outliers.
Key ideas
9DHA is far more than fuel
DHA works as a hormone precursor, as structural material making up roughly 40% of the brain's unsaturated fats, and as an anti-inflammatory agent. Burning it for energy wastes its most important roles.
The carrier decides the destination
Lysophosphatidylcholine (LPC) DHA locks onto the MFSD2A transporter and crosses into the brain, while ordinary triglyceride fish oil accumulates more in fat tissue. Gram for gram, the phospholipid form reaches the brain best.
APOE4 is a multiplier, not destiny
One copy sits in about 25% of people but 65% of Alzheimer's patients; two copies raise risk 10-15 fold and more so in women. Yet populations exist who carry two copies without disease, so lifestyle still matters.
The E4 brain burns through DHA
Young E4 brains take up DHA faster and clear it with a much shorter half-life, suggesting they burn it for energy rather than preserving it for structure. That is the logic behind supplementing more aggressively.
Sex differences are under-taught
Some DHA-synthesis genes sit on the X chromosome and escape inactivation, and statin-linked blood-sugar rises in women track with suppressed DHA. In animals, adding fish oil restored glucose control.
Ezetimibe's surprising brain angle
A hypothesis-naive screen found ezetimibe crosses into the brain and interrupts a hexokinase and 14-3-3 protein interaction linked to misfolding. In cell models it lowered amyloid and tau and raised autophagy by 40%.
Lithium orotate and GSK3-beta
A Harvard-led Nature study found lithium depleted and sequestered in Alzheimer's brains; among 16 salts, orotate was the standout GSK3-beta inhibitor. The micro-dose discussed is milligrams of the molecule, not psychiatric doses.
The outlier who shouldn't exist
Seven years at 700 cholesterol with zero plaque on a coronary CT angiogram anchors his argument that LDL is causal but not automatically important. Risk, he insists, depends on who the patient is.
Everything is repurposed
A month of sardines seemed to drive thermogenesis via the omega-3 hormone 12-HEPE, whose receptor turned out to be a smell receptor also expressed in liver, brain and brown fat — a vivid reminder of how interconnected physiology is.
Practical takeaways
7- 1
Look for the phospholipid form 10:00
If the goal is the brain, the LPC or lyso form of DHA is more efficient than standard triglyceride fish oil; fish roe and krill are natural sources.
- 2
Match dose to risk 19:00
Around 2g combined EPA and DHA suits most people, while APOE4 carriers may choose to go more aggressive because their brains appear to burn through it faster. This is wellness framing, not medical advice.
- 3
Guard sleep if you carry E4 42:00
Risk carriers have little margin; chronic sleep deprivation hits an E4 brain harder, so protecting deep sleep is a foundational habit.
- 4
Context beats lower-is-better 54:00
Metabolic health, inflammation and individual profile shape whether lipid-lowering helps, so a single number is a poor guide on its own.
- 5
Exercise raises NAD naturally 2:48:00
NAD runs low in Alzheimer's brains and exercise is the reliable lever, alongside intermittent fasting and occasional bouts of ketosis.
- 6
Know the preservation stack 2:46:00
Omega-3s, good sleep, lithium orotate, NAD support, creatine and exercise recur as topics worth researching, framed as education rather than prescriptions.
- 7
Creatine beyond the gym 2:50:00
A study using 3g creatine with a probiotic to aid uptake showed clinical improvements in depression; creatine also supports brain energy metabolism.
Topics & chapters
15The paradox and the provocateur
A cold open on the 700 cholesterol case, APOE4 and self-experiments, then the core puzzle: fish lowers Alzheimer's risk but standard omega-3 trials disappoint.
What DHA actually does in the brain
DHA as hormone precursor, structural building block and anti-inflammatory agent — why the brain cannot function without it.
Carriers matter: the phospholipid advantage
Triglyceride versus lysophosphatidylcholine DHA and the MFSD2A transporter that ferries it across the blood-brain barrier.
Water-maze evidence and dosing
Mice given LPC-DHA learn faster in the Morris water maze, and the open question of dose equivalence for a more brain-targeted form.
APOE4 decoded
Three alleles, one from each parent, sex differences in risk, and why the gene is best seen as a multiplier rather than a verdict.
The burn-hot-die-young brain
E4 links to higher IQ and hyperexcitability early in life, and to faster DHA turnover that argues for aggressive omega-3 intake.
Women, menopause and statins
Estrogen loss, cerebral glucose intolerance, X-chromosome DHA genes and why statins carry more muscle and blood-sugar risk in women.
Statins and dementia: it depends who
Pleiotropic effects, the weak link between LDL reduction and outcomes, and mitochondrial concerns for a lean, metabolically healthy person.
Ezetimibe's surprising brain angle
A screen finds ezetimibe crossing into the brain to interrupt a toxic protein interaction, lowering amyloid and tau and boosting autophagy.
Amyloid versus tau
Why tau tangles may be the real driver, the fabricated amyloid research that set the field back, and p-tau 217 as a tracking biomarker.
Lithium, GSK3-beta and glymphatics
The Nature lithium-orotate study, GSK3-beta as a tau kinase, and the glymphatic clean-up that deep sleep and 40Hz devices might enhance.
Gene editing the future
Prime editing, meeting Jennifer Doudna, and the prospect of converting APOE4 to E2 with safer next-generation tools.
The 700 cholesterol case
Causality versus importance, the oxygen-and-fire analogy, the lean mass hyperresponder phenotype and the Oreo experiment.
The sardine experiment
A month of a thousand sardines, a strange body odour, cold resistance, and 12-HEPE thermogenesis routed through a smell receptor.
Ketones, creatine and the preservation stack
Ketones as brain fuel that may clear misfolded proteins, the creatine-and-depression study, GLP-1s for the brain and the peptide landscape.